Depression and anxiety in supportive oncology

Supportive Oncology

Volumn , Issue , 2011, Pages 528-540

  Li, Madeline ^a,b   Boquiren, Virginia ^a   Lo, Christopher ^a   Rodin, Gary ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882883062     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1015-1.00052-7     Document Type: Chapter

References (135)

1. Roth A.J., Massie M.J. Anxiety and its management in advanced cancer. Curr Opin Support Palliat Care 2007, 1:50-56.
2. Desaive P., Ronson A. Stress spectrum disorders in oncology. Curr Opin Oncol 2008, 20:378-385.
3. Lo C., Li M., Rodin G. The assessment and treatment of distress in cancer patients: overview and future directions. Minerva Psichiatr 2008, 49:129-143.
4. Grassi L., Indelli M., Marzola M., et al. Depressive symptoms and quality of life in home-care assisted cancer patients. J Pain Symptom Manage 1996, 12:300-307.
5. Colleoni M., Mandala M., Peruzzotto G., et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000, 356:1326-1327.
6. Prieto J.M., Blanch J., Atala J., et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 2002, 20:1907-1917.
7. Rodin G., Zimmermann C., Rydall A., et al. The desire for hastened death in patients with metastatic cancer. J Pain Symptom Manage 2007, 33:661-665.
8. Chochinov H.M., Wilson K.G., Enns M., et al. Desire for death in the terminally ill. Am J Psychiatry 1995, 152:1185-1191.
9. Chochinov H.M., Tataryn D., Clinch J.J., et al. Will to live in the terminally ill. Lancet 1999, 354:816-819.
10. Stommel M., Given B.A., Given C.W. Depression and functional status as predictors of death among cancer patients. Cancer 2002, 94:2719-2727.
11. Faller H., Bulzebruck H., Drings P., et al. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry 1999, 56:756-762.
12. Rodin G., Lo C., Mikulincer M., et al. Pathways to distress: the multiple determinants of depression, hopelessness and the desire for hastened death in metastatic cancer patients. Soc Sci Med 2009, 68:562-569.
13. Li M., Rodin G. Depression and illness. Handbook of health psychology and behavioral medicine 2010, Guilford Press, New York. J.M. Suls, K.W. Davidson, R.W. Kaplan (Eds.).
14. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, American Psychiatric Association Press, Washington, DC, Text revision (DSM-IV-TR). 4th ed.
15. Li M., Hales S. Adjustment disorders. Psycho-oncology 2010, 303-310. Oxford University Press, New York, NY. 2nd ed. J. Holland, W. Breitbert, P. Jacobsen (Eds.).
16. Kleinman A. The normal, the pathological, and the existential. Compr Psychiatry 2008, 49:111-112.
17. Horwitz A.V., Wakefield J.C. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder 2007, Oxford University Press, New York, NY.
18. Casey P., Dowrick C., Wilkinson G. Adjustment disorders: fault line in the psychiatric glossary. Br J Psychiatry 2001, 179:479-481.
19. Strain J.J., Diefenbacher A. The adjustment disorders: the conundrums of the diagnoses. Compr Psychiatry 2008, 49:121-130.
20. Derogatis L., Morrow G.R., Fetting J., et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983, 249:751-757.
21. Strain J.J., Smith G.C., Hammer J.S., et al. Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry 1998, 20:139-149.
22. Kissane D.W., Clarke D.M., Street A.F. Demoralization syndrome-a relevant psychiatric diagnosis for palliative care. J Palliat Care 2001, 17:12-21.
23. Aapro M.S., Molassiotis A., Olver I. Anticipatory nausea and vomiting. Support Care Cancer 2005, 13:117-121.
24. Stark D., Kiely M., Smith A., et al. anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002, 20:3137-3148.
25. Brintzenhofe-Szoc K.M., Levin T.T., Li Y., et al. Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 2009, 50:383-391.
26. American Psychiatric Association. DSM-5 development. DSM-5: The future of psychiatric diagnosis. Available at:, accessed April 20, 2010. http://www.DSM5.org.
27. Coryell W., Endicott J., Andreasen N.C., et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 1998, 145:293-300.
28. Fava M., Uebelacker L.A., Alpert J.E., et al. Major depressive subtypes and treatment response. Biol Psychiatry 1997, 43:568-576.
29. Brown C., Schulberg H.C., Madonia M.J., et al. Treatment outcomes for primary-care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996, 153:1293-1300.
30. Kendler K.S. Explanatory models for psychiatric illness. Am J Psychiatry 2008, 165:695-702.
31. Annunziata M.A., Muzzatti B., Bidoli E. Psychological distress and needs of cancer patients: a prospective comparison between the diagnostic and therapeutic phase. Support Care Cancer 2010, Feb 5 [Epub ahead of print].
32. Hinnen C., Ranchor A.V., Sanderman R., et al. Course of distress in breast cancer patients, their partners, and matched control couples. Ann Behav Med 2008, 36:141-148.
33. Stanton A.L., Ganz P.A., Rowland J.H., et al. Promoting adjustment after treatment for cancer. Cancer 2005, 104(suppl 11):2608-2613.
34. Kangas M., Henry J.L., Bryant R.A. Posttraumatic stress disorder following cancer: a conceptual and empirical review. Clin Psychol Rev 2002, 22:499-524.
35. Mundy E.A., Blanchard E.B., Cirenza E., et al. Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behav Res Ther 2000, 38:1015-1027.
36. Tjemsland L., Soreide J.A., Malt U.F. Traumatic distress symptoms in early breast cancer. I: Acute response to diagnosis. Psychooncology 1996, 5:1-8.
37. Tjemsland L., Soreide J.A., Malt U.F. Traumatic distress symptoms in early breast cancer. II: Outcome six weeks postsurgery. Psychooncology 1996, 5:295-303.
38. Lo C., Zimmermann C., Rydall A., et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol 2010, 28:3084-3089.
39. Breslau N., Davis G.C., Peterson E.L., et al. A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection. Biol Psychiatry 2000, 48:902-909.
40. Ronson A. Psychiatric disorders in oncology: recent therapeutic advances and new conceptual frameworks. Curr Opin Oncol 2004, 16:318-323.
41. Lo C., Lin J., Gagliese L., et al. Age and depression in patients with metastatic cancer: the protective effects of attachment security and spiritual well-being. Ageing Society 2010, 30:325-336.
42. Hopwood P., Haviland J., Mills J., et al. START Trial Management Group. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast. Breast 2007, 16:241-251. [Erratum appears in, Note: START Trial Management Group added].
43. Rodin G., Walsh A., Zimmermann C., et al. The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancer. Psychooncology 2007, 16:1080-1091.
44. Miller S., Lo C., Gagliese L., et al. Patterns of depression in cancer patients: an indirect test of gender-specific vulnerabilities to depression. Soc Psychiatry Psychiatr Epidemiol 2010, Jun 25 [Epub ahead of print].
45. Gurevich M., Devins G.M., Rodin G. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 2002, 43:259-281.
46. Carlson L.E., Angen M., Cullum J., et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004, 90:2297-2304.
47. Cheung W.Y., Le L.W., Gagliese L., et al. Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer. Support Care Cancer 2010, Mar 24 [Epub ahead of print].
48. Parker P.A., Baile W.F., De Moor C., et al. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology 2003, 12:183-193.
49. Manne S., Rini C., Rubin S., et al. Long-term trajectories of psychological adaptation among women diagnosed with gynaecological cancers. Psychosom Med 2008, 70:677-687.
50. Helgeson V.S., Snyder P., Seltman H. Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 2004, 23:3-15.
51. Patten S.B., Barbui C. Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom 2004, 73:207-215.
52. Dantzer R., O'Connor J.C., Freund G.G. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
53. Miller A.H., Ancoli-Israel S., Bower J.E., et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 2008, 26:971-982.
54. Levin T.T., Riskind J.H., Li Y. Looming threat-processing style in a cancer cohort. Gen Hosp Psychiatry 2007, 29:32-38.
55. De Vries J., Van der Steeg A.F., Roukema J.A. Trait anxiety determines depressive symptoms and fatigue in women with an abnormality in the breast. Br J Health Psychol 2009, 14:143-157.
56. Asmundson G.JG., Dristi D.W., Hadjistavropoulos H.D. Anxiety sensitivity and disabling chronic health conditions: state of the art and future directions. Scand J Behav Ther 2000, 29:100-117.
57. Classen C.C., Kraemer H.C., Blasey C., et al. Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology 2008, 17:438-447.
58. Roesch S.C., Adams L., Hines A., et al. Coping with prostate cancer: a meta-analytic review. J Behav Med 2005, 28:281-293.
59. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004, 32:57-71.
60. Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol 2008, 20:353-359.
61. Ell K., Quon B., Quinn D.I., et al. Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen Hosp Psychiatry 2007, 29:223-231.
62. Clarke D.M., Currie K.C. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust 2009, 7:S54-S60.
63. Evans D.L., Charney D.S., Lewis L., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
64. Kessler R.C., Chiu W.T., Demler O., et al. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005, 62:617-627.
65. Miovic M., Block S. Psychiatric disorders in advanced cancer. Cancer 2007, 110:1665-1676.
66. Green B.L., Rowland J.H., Krupnick J.L., et al. Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics 1998, 9:102-111.
67. Okamura H., Watanabe T., Narabayashi M., et al. Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat 2000, 61:131-137.
68. Mehnert A., Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology 2007, 16:181-188.
69. Gandubert C., Carriere I., Escot C., et al. Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psychooncology 2009, 18:1029-1037.
70. Kangas M., Henry J., Bryant R. Correlates of acute stress disorder in cancer patients. J Trauma Stress 2007, 20:325-334.
71. Gudmundsdottir H., Gudmundsdottir A., Gudmundsdottir D. PTSD and psychological distress in Icelandic parents of chronically ill children: does social support have an effect on parental distress?. Scand J Psychol 2006, 47:303-312.
72. Trask P.C. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 2004, 32:80-92.
73. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
74. Hopko D.R., Bell J.L., Armento M.E., et al. The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 2008, 26:31-51.
75. Beck A.T., Steer R.A., Brown G.K. Manual for Beck Depression Inventory-II 1996, Psychological Corporation, Harcourt Brace and Company, San Antonio, TX.
76. Spitzer R.L., Kroenke K., Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282:1737-1744.
77. Ell K., Xie B., Quon B., et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008, 26:4488-4496.
78. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
79. Walker J., Postma K., McHugh G.S., et al. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 2007, 63:83-91.
80. Spielberger C.D. Manual for the State-Trait Anxiety Inventory 1983, Consulting Psychologists Press, Palo Alto, CA.
81. Spitzer R.L., Kroenke K., Williams J.B., et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166:1092-1097.
82. Kroenke K., Spitzer R.L., Williams J.BW., et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
83. Beck A.T., Steer R.A. Beck Anxiety Inventory: Manual 1993, The Psychological Corporation, Harcourt Brace and Company, San Antonio, TX.
84. Leyfer O.T., Ruberg J.L., Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord 2006, 20:444-458.
85. Weiss D.S., Marmar C.R. The Impact of Event Scale-Revised. Assessing psychological trauma and PTSD 1997, 399-412. The Guilford Press, New York, NY. J.P. Wilson, T.M. Keane (Eds.).
86. Horowitz M., Wilner N., Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979, 41:209-218.
87. Cardena E., Koopman C., Classen C., et al. Psychometric properties of the Stanford Acute Stress Reaction Questionnaire (SASRQ): a valid and reliable measure of acute stress. J Trauma Stress 2000, 13:719-734.
88. Pedersen A.F., Zachariae R. Cancer, acute stress disorder, and repressive coping. Scand J Psychol 2010, 51:84-91.
89. Ellis J., Lin J., Walsh A., et al. Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital status. J Clin Oncol 2009, 27:699-705.
90. Vodermaier A., Linden W., Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009, 101:1-25.
91. Loscalzo M.J., Clark K.L. Problem-related distress in cancer patients drives requests for help: a prospective study. Oncology 2007, 21:1133-1138.
92. Holland J.C., Bultz B.D. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 2007, 5:3-7.
93. Cancer care for the whole patient: meeting psychosocial health needs: Institute of Medicine report 2007, Institute of Medicine, The National Academies Press, Washington, DC.
94. NCCN Guidelines for Supportive Care: Distress Management 2011, National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, Version 1. Available at:, accessed November 24, 2010. http://www.nccn.org;.
95. Guidance on cancer services 2004, National Institute for Clinical Excellence (NICE), NICE, London, UK.
96. National Psychosocial Oncology Standards of Canada; 1999, Canadian Association of Psychosocial Oncology (CAPO), Principle 7: Assessment of need. Available at:, accessed November 24, 2010. http://www.nccn.org;.
97. Guide to implementing screening for distress: the 6th vital sign moving towards person-centered care 2009, Canadian Partnership Against Cancer, Cancer Journey Action Group, Canadian Partnership Against Cancer, Toronto, ON, Canada.
98. Palmer S.C., Coyne J.C. Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J Psychosom Res 2003, 54:279-287.
99. Schade C.P., Jones E.R., Wittlin B.J. A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv 1998, 49:55-61.
100. Jacobsen P.B., Donovan K.A., Swaine Z.N., et al. Management of anxiety and depression in adult cancer patients: toward an evidence-based approach. Oncology: an evidence-based approach 2006, 1552-1579. Springer, Philadelphia, PA. A.E. Change, D.F. Hayes, H.I. Pass (Eds.).
101. Cuijpers P., van Straten A., Andersson G., et al. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008, 76:909-922.
102. Garland S.N., Carlson L.E., Cook S., et al. A nonrandomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating posttraumatic growth and spirituality in cancer outpatients. Support Care Cancer 2007, 15:949-961.
103. Strong V., Waters R., Hibberd C., et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 2008, 372:40-48.
104. Dolbeaut S., Cayrou S., Brédart A., et al. The effectiveness of a psycho-educational group after early-stage breast cancer treatment: results of a randomized French study. Psychooncology 2009, 18:647-656.
105. Kissane D.W., Levin T., Hales S., et al. Psychotherapy for depression in cancer and palliative care. Depression and cancer 2011, 177-206. World Psychiatric Association, Chêne-Bourg, Switzerland. D.W. Kissane, M. Maj, N. Sartorius (Eds.).
106. Akechi T., Okuyama T., Onishi J., et al. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev 2008, (2). CD005537.
107. Hales S., Lo C., Rodin G. Managing Cancer and Living Meaningfully (CALM) treatment manual: an individual psychotherapy for patients with advanced cancer. Psychosocial Oncology and Palliative Care, Princess Margaret Hospital, University Health Network 2010, Toronto, Canada.
108. Coyne J.C., Lepore S.J., Palmer S.C. Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks. Ann Behav Med 2006, 32:104-110.
109. Andrykowski M.A., Manne S.L. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. Ann Behav Med 2006, 32:93-97.
110. Schneider S., Moyer A., Knapp-Oliver S., et al. Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med 2010, 33:1-14.
111. Coyne J.C., Stefanek M., Thombs B.D., et al. Time to let go of the illusion that psychotherapy extends the survival of cancer patients: reply to Kraemer, Kuchler, and Spiegel. Psychol Bull 2009, 135:179-182.
112. Kraemer H.C., Kuchler T., Spiegel D. Use and misuse of the consolidated standards of reporting trials (CONSORT) guidelines to assess research findings: comment on Coyne, Stefanek, and Palmer. Psychol Bull 2009, 135:173-178.
113. Kissane D. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 2009, 18:1-5.
114. Coyne J.C., Tennen H. Positive psychology in cancer care: bad science, exaggerated claims, and unproven medicine. Ann Behav Med 2010, 39:16-26.
115. Aspinwall L.G., Tedeschi R.G. The value of positive psychology for health psychology: progress and pitfalls in examining the relation of positive phenomena to health. Ann Behav Med 2010, 39:4-15.
116. Krishnan K.R. Treatment of depression in the medically ill. J Clin Psychopharmacol 2005, 25(4 suppl 1):S14-S18.
117. Rodin G., Lloyd N., Katz M., et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer 2007, 15:123-136.
118. Rayner L., Price A., Evans A., et al. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010, (3). CD007503.
119. Loprinzi C.L., Kugler J.W., Sloan J.A., et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000, 356:2059-2063.
120. Davis J.L., Smith R.L. Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care 1999, 22:1909-1910.
121. Jann M.W., Slade J.H. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007, 27:1571-1587.
122. Muller N., Schennach R., Riedel M., et al. Duloxetine in the treatment of major psychiatric and neuropathic disorders. Expert Rev Neurother 2008, 8:527-536.
123. Observation: olanzapine and mirtazapine for multiple palliation. J Support Oncol 2003, 1-64. J. Von Roenn (Ed.).
124. Tan L., Liu J., Liu X., et al. Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. J Exp Clin Cancer Res 2009, 28:131.
125. Holmes A., Heilig M., Rupniak N.M., et al. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 2003, 24:580-588.
126. Kramer M.S., Winokur A., Kelsey J., et al. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology 2004, 29:385-392.
127. Nemeroff C.B. New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum Psychopharmacol 2002, 17:(Supp1)-S13-S16.
128. Navari R.M., Brenner M.C., Wilson M.N. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat 2008, 112:197-201.
129. Fitzgerald P.B., Daskalakis Z.J. The use of repetitive transcranial magnetic stimulation and vagal nerve stimulation in the treatment of depression. Curr Opin Psychiatry 2008, 21:25-29.
130. Iosifescu D.V. Treating depression in the medically ill. Psychiatr Clin North Am 2007, 30:77-90.
131. Roy-Byrne P.P., Davidson K.W., Kessler R.C., et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008, 30:208-225.
132. Kapczinski F.K., Silva de Lima M., dos Santos Souza J.S., et al. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev 2003, (2). CD003592.
133. Stein D.J., Ipser J.C., Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006, (1). CD002795.
134. American Psychiatric Association. Treatment of patients with acute stress disorder and posttraumatic stress disorder. Available at:, accessed April 22, 2010. http://www.psychiatryonline.com/pracGuide/pracGuideTopic_11.aspx.
135. Canadian Psychiatric Association. Clinical practice guidelines: management of anxiety disorders-posttraumatic stress disorder. Available at:, accessed April 23, 2010. http://publications.cpa-apc.org/media.php?mid=446.